Home/Filings/4/0002095250-25-000006
4//SEC Filing

Pai Panandiker Kaya Kamlesh 4

Accession 0002095250-25-000006

CIK 0001691082other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 4:15 PM ET

Size

5.8 KB

Accession

0002095250-25-000006

Insider Transaction Report

Form 4
Period: 2025-12-10
Pai Panandiker Kaya Kamlesh
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-12-10+195,000195,000 total
    Exercise: $21.36Exp: 2035-12-09Common Stock (195,000 underlying)
Footnotes (1)
  • [F1]One fourth (1/4) of the shares subject to the option award shall vest on November 10, 2026 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments on the last calendar day of each month with the first monthly installment occurring on December 31, 2026, subject to the Reporting Person's continuous service through each such vesting date.

Issuer

LB PHARMACEUTICALS INC

CIK 0001691082

Entity typeother

Related Parties

1
  • filerCIK 0002095250

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:15 PM ET
Size
5.8 KB